Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Ubiquitin proteasome pathway: implications and advances in cancer therapy.

Shah SA, Potter MW, Callery MP.

Surg Oncol. 2001 Jul-Aug;10(1-2):43-52. Review.

PMID:
11719028
2.

Targeting the ubiquitin-proteasome pathway in breast cancer.

Cardoso F, Ross JS, Picart MJ, Sotiriou C, Durbecq V.

Clin Breast Cancer. 2004 Jun;5(2):148-57. Review.

PMID:
15245620
3.

Deadly encounter: ubiquitin meets apoptosis.

Jesenberger V, Jentsch S.

Nat Rev Mol Cell Biol. 2002 Feb;3(2):112-21. Review.

PMID:
11836513
4.

The proteasome, a new target for cancer therapy.

Gillessen S, Groettup M, Cerny T.

Onkologie. 2002 Dec;25(6):534-9. Review.

PMID:
12566898
5.

Ubiquitin proteasome inhibition and cancer therapy.

Shah SA, Potter MW, Callery MP.

Surgery. 2002 Jun;131(6):595-600. Review. No abstract available.

PMID:
12075171
6.

Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases.

Golab J, Bauer TM, Daniel V, Naujokat C.

Clin Chim Acta. 2004 Feb;340(1-2):27-40. Review.

PMID:
14734194
7.

The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling.

Rome S, Meugnier E, Vidal H.

Curr Opin Clin Nutr Metab Care. 2004 May;7(3):249-54. Review.

PMID:
15075914
8.

Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.

Dou QP, Smith DM, Daniel KG, Kazi A.

Prog Cell Cycle Res. 2003;5:441-6. Review.

PMID:
14593738
9.

The proteasome as a target for cancer therapy.

Voorhees PM, Dees EC, O'Neil B, Orlowski RZ.

Clin Cancer Res. 2003 Dec 15;9(17):6316-25. Review.

10.

The ubiquitin-proteasome system and its role in ethanol-induced disorders.

Donohue TM Jr.

Addict Biol. 2002 Jan;7(1):15-28. Review.

PMID:
11900619
11.

Rings, chains and ladders: ubiquitin goes to work in the neuron.

Johnston JA, Madura K.

Prog Neurobiol. 2004 Jul;73(4):227-57. Review.

PMID:
15261394
12.

Nature and role of proteasomes in maturation of fish oocytes.

Tokumoto T.

Int Rev Cytol. 1999;186:261-94. Review.

PMID:
9770302
13.

Recent advances in the identification and development of 20S proteasome inhibitors.

García-Echeverría C.

Mini Rev Med Chem. 2002 Jun;2(3):247-59. Review.

PMID:
12370066
14.

The proteasome in cancer biology and treatment.

Pajonk F, McBride WH.

Radiat Res. 2001 Nov;156(5 Pt 1):447-59. Review.

PMID:
11604057
15.

Proteasome inhibitors as anti-cancer agents.

Murray RZ, Norbury C.

Anticancer Drugs. 2000 Jul;11(6):407-17. Review.

PMID:
11001381
16.

The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner.

Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR.

J Cell Sci. 2000 Dec;113 Pt 23:4363-71.

17.

Regulatory roles of ubiquitin-proteasome pathway in pig oocyte meiotic maturation and fertilization.

Sun QY, Fuchimoto D, Nagai T.

Theriogenology. 2004 Jul;62(1-2):245-55.

PMID:
15159117
18.

Apoptosis and the proteasome.

Grimm LM, Osborne BA.

Results Probl Cell Differ. 1999;23:209-28. Review.

PMID:
9950035
19.

The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.

Motegi A, Murakawa Y, Takeda S.

Cancer Lett. 2009 Sep 28;283(1):1-9. doi: 10.1016/j.canlet.2008.12.030. Epub 2009 Feb 6. Review.

PMID:
19201084
20.

Monitoring the ubiquitin/proteasome system in conformational diseases.

Lindsten K, Dantuma NP.

Ageing Res Rev. 2003 Oct;2(4):433-49. Review.

PMID:
14522245

Supplemental Content

Support Center